Feb. 14 at 5:11 PM
$ALXO deep dive of Venbio history here.
Majority of their shares were issued pre IPO and converted at IPO to common stock 1:1...approx 8.8 mil shares owned by them on IPO day at under
$10 cost basis. They never sold any of these shares at the huge prices of
$50-
$100 post IPO
Reading through all of the filings and factoring in the most recent offering Venbio participated in....I'm able to account for 11,869,818 of the 13,163,549 shares reported by Venbio
Those 11,869,818 shares have a cost basis of
$4.79 a share
That includes 5,498,608 series A convertible at
$6.58 a share, 490,411 series b at
$9.4972, 1,052,950 series c at 9.4972, and the most recent offering 3,463,624 at
$1.57.
They were awarded 1,364,225 shares as accrued dividends at the IPO date(0 cost basis)
Still trying to track down those other approx 1.3 mil shares to get to the 13,163,549 holding total from Feb 4 filing. But I think it's fairly safe to say they have a
$4-
$6 basis
